PGR and triple-negative breast carcinoma: For triple-negative breast cancer (TNBC) that lacks oestrogen receptor (ER), progesterone receptor (PR) and epidermal growth factor receptor 2 (HER2) amplification, chemotherapy is used either alone or in adjuvant or neoadjuvant settings2.